SunLink Health Systems Inc - Asset Resilience Ratio

Latest as of March 2025: 42.73%

SunLink Health Systems Inc (SSY) has an Asset Resilience Ratio of 42.73% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of SunLink Health Systems Inc to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$7.47 Million
Cash + Short-term Investments

Total Assets

$17.47 Million
All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how SunLink Health Systems Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of SunLink Health Systems Inc.

Liquid Assets Composition Over Time

This chart breaks down SunLink Health Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read SSY liabilities breakdown for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $7.47 Million 42.73%
Short-term Investments $0.00 0%
Total Liquid Assets $7.47 Million 42.73%

Asset Resilience Insights

  • Very High Liquidity: SunLink Health Systems Inc maintains exceptional liquid asset reserves at 42.73% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

SunLink Health Systems Inc Industry Peers by Asset Resilience Ratio

Compare SunLink Health Systems Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Raia Drogasil S.A
SA:RADL3
Pharmaceutical Retailers 0.46%
Luyan Pharma Co Ltd
SHE:002788
Pharmaceutical Retailers 0.00%
Empreendimentos Pague Menos S.A
SA:PGMN3
Pharmaceutical Retailers 0.00%
d1000 Varejo Farma Participações S.A
SA:DMVF3
Pharmaceutical Retailers 2.05%
High Tide Inc
V:HITI
Pharmaceutical Retailers 0.02%
Yifeng Pharmacy
SHG:603939
Pharmaceutical Retailers 19.16%
Laobaixing Pharmacy
SHG:603883
Pharmaceutical Retailers 0.01%
Yunnan Hongxiang Yixintang
SHE:002727
Pharmaceutical Retailers 4.78%

Annual Asset Resilience Ratio for SunLink Health Systems Inc (2012–2024)

The table below shows the annual Asset Resilience Ratio data for SunLink Health Systems Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-06-30 34.79% $7.17 Million $20.61 Million +15.51pp
2023-06-30 19.28% $4.49 Million $23.27 Million -12.28pp
2021-06-30 31.56% $9.96 Million $31.56 Million -8.42pp
2020-06-30 39.98% $11.18 Million $27.97 Million +8.28pp
2019-06-30 31.70% $7.74 Million $24.42 Million +18.50pp
2018-06-30 13.20% $3.46 Million $26.18 Million -21.32pp
2017-06-30 34.52% $12.20 Million $35.34 Million +27.25pp
2016-06-30 7.27% $3.26 Million $44.84 Million --
2015-06-30 0.00% $0.00 $57.13 Million --
2014-06-30 0.00% $0.00 $63.85 Million --
2013-06-30 0.24% $160.00K $68.00 Million --
2012-06-30 0.00% $0.00 $79.17 Million --
pp = percentage points

About SunLink Health Systems Inc

NYSE MKT:SSY USA Pharmaceutical Retailers
Market Cap
$7.85 Million
Market Cap Rank
#27707 Global
#5691 in USA
Share Price
$1.12
Change (1 day)
+0.00%
52-Week Range
$1.12 - $1.12
All Time High
$4.85
About

As of August 14, 2025, SunLink Health Systems, Inc. was acquired by Regional Health Properties, Inc. SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. The company operates through Healthcare Services and Pharmacy segments. It is also involved in provision of specialty and non-specialty pharmaceutical and biological… Read more